12:00 AM
 | 
Jun 22, 2009
 |  BC Week In Review  |  Company News  |  Deals

CeNeRx, Krenitsky Pharmaceuticals deal

CeNeRx received exclusive, worldwide rights from Krenitsky to develop and commercialize CXB909 to treat and prevent neuropathies and neurodegenerative disorders. The oral small molecule that...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >